Caracterização imunofenotípica e potencial de diferenciação de células-tronco mesenquimais provenientes de medula óssea, tecido adiposo e cordão umbilical de equinos

Pós-graduação em Medicina Veterinária - FMVZ

Estudo do potencial de diferenciação de células-tronco mesenquimais equinas oriundas do sangue da medula óssea cultivadas sobre um filme multicamadas de biopolímeros: quitosna, HA e CMC

Pós-graduação em Biologia Geral e Aplicada - IBB

A influência dos fatores socioeconômicos na sobrevida global dos pacientes submetidos ao transplante de células tronco hematopoéticas

Pós-graduação em Pesquisa e Desenvolvimento (Biotecnologia Médica) - FMB

Avaliação da imunomarcação de células-tronco tumorais em carcinossarcomas mamários e carcinomas em tumores mistos em cadelas

Cancer stem cells belong to a small population of cells within the tumor with properties of self-renewal and differentiation into other cell types. In this study, the behavior of both portions, mesenchymal and epithelial, was evaluated. Six carcinosarcomas (CSs), 11 carcinomas within mixed tumors (CWMTs) grade I, 11 grade II, and 10 grade III were evaluated. In the epithelial portions of the CS and CWMTs was observed immunostaining for antibodies CD44, CD24, Oct-4 and ALDH-1. In the mesenchymal portions of the CS, in the epithelial portions of CMTs grades II and III no immunostaining for ALDH-1 was found. It was concluded that the tumor stem cells are expressed in equal proportions in the epithelial and mesenchymal portions of the CS. No immunostaining in the mesenchymal portions of well-differentiated CWMTs was seen.

Efeito do selante de fibrina derivado de peçonha de serpente associado a células-tronco mesenquimais na cicatrização de ferida cirúrgica em ratos

Pós-graduação em Doenças Tropicais - FMB

Caracterização, criopreservação e diferenciação in vitro de células tronco, derivadas de amniótica e gelatina de Wharton canina, visando a formação de um banco de células tronco

Pós-graduação em Biotecnologia Animal - FMVZ

Estudo dos mecanismos envolvidos no processo de diferenciação em linhagem osteogênica de células-tronco mesenquimais da medula óssea de ratos Wistar e ratos espontaneamente hipertensos (SHR)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Análise comparativa de diferentes metodologias para cultivo de células-tronco mesenquimais derivadas de tecido muscular

Pós-graduação em Biociências - FCLAS

Produção de anticorpos monoclonais murinos dirigidos contra células-tronco mesenquimais de coelho

Mesenchymal stem cells (MSCs) are a heterogeneous population of cells that proliferate in vitro as plastic-adherent cells, have fibroblast-like morphology and can differentiate into bone, cartilage and fat cells. Therapeutic potential of MSCs have been studied in experimental models, such as rabbit, in Laboratory of Cell Engineering of Botucatu. However, no specific markers have been reported for expanded rabbit MSCs, which hampers the isolation of pure MSC populations by immunophenotypic characterization. Thus, the objective of this study was to produce monoclonal antibodies (mAbs) to rabbit MSCs. MSCs derived from rabbit bone marrow (BM) were isolated, cultured, expanded ex vivo, and immunized into three BALB/c mices, and spleen cells subsequently harvested were used to generate hibridoma cell lines secreting antibodies against MSCs. Hybridoma cells were screened by flow cytometry and antibody-producing cells were subjected to subsequent rounds of retests. MSC1-160 obtained the best positivity for IgG expression and was cloned by limiting dilutions and micromanipulation. Ascitic fluid from ten best clones was purified by affinity chromatography in Protein A-sepharose CL-4B column and purification control was performed by electrophoresis in agarose gels. The purified IgG were tested against rabbit MSCs, obtaining high positivity by flow Cytometry. In conclusion, we developed 10 mAbs, MSC1-160 A20, A30, A41, A47, A55, A60, A63, A69, A81, and A82, that recognize rabbit MSC cell surface antigens showing potential for immunophenotypic characterization of rabbit MSC cell lines

Uso de células-tronco para o tratamento de tendinite em eqüinos

Brazil has the fourth largest horse herd in the world, this is due the recognition and appreciation that the different equestrian games are having within the country. Injuries of the tendon, especially in the digital flexor tendon, are the main cause of athletic life reduction among horses. The treatment of tendinitis in horses seeks full recovery of the damage tissue reestablishing the function previously lost, however conventional treatments have proven to be ineffective when considered the quality of the scar tissue and the rate of recurrence. Due to this, the use of adult stem cells to the treatment of musculoskeletal injuries of horses has been studied for some time. This method of treatment consists of aspiration of bone marrow or removal of subcutaneous fat tissue and implantation of these cells in the injured tissue. After obtaining the bone marrow the implantation can be performed with total bone marrow, with the mononuclear fraction of MSC or with cells cultured in vitro. From the fat tissue is used the stromal vascular fraction obtained by collagenase digestion, followed or not by cell culture. According to some studies, cell therapy with material obtained from bone marrow or adipose tissue has shown to be viable, given that these materials are abundant in repair components such as mesenchymal stem cells (MSC), growth factors and other components of the collagen matrix. Several studies using both types of cells have shown great potential and promising clinical results. However, knowledge of the biology and characterization of these cells remain largely unknown, and therefore is needed great care and caution when using stem cells for the treatment of musculoskeletal disorders in horses

Transplante de medula óssea para suporte de células tronco hematopoiéticas em cães acometidos por linfoma

Lymphoma represents the most prevalent hematopoietic malignancy in small animal medicine. It is highly responsible to chemotherapy and therefore several protocols are used as therapeutic tools. For that reason, the bone marrow transplantation, enshrined in human medicine through initial trial in canine patients, has increasingly become the focus of studies in order to make it a reality also in veterinary medicine. First, the treatment with the chosen chemotherapy protocol is made. As complete remission of lymphoma is observed, it must be initiated the bone marrow harvesting. The obtained material is subjected to the processes of erythrocyte depletion, plasma depletion, cryoprotectants addition, total nuclear cells counting, hematopoietic progenitor quantification, analysis of cell viability and freezing. Following that, with radiotherapy or application of cyclophosphamide, the conditioning phase of the patient who is receiving the transplantation is carried out. The bags containing hematopoietic stem cells are then thawed and transplanted into the receptor organism. Support with hematopoietic stem cells allows the use of lethal doses of chemotherapy or radiotherapy and has been shown to considerably raise the disease remission time and survival rate of the canine patients

Papel reparador e imunomodulador das células-tronco mesenquimais (CTMs) deficientes de receptor para interferon-gamma (IFNy) em modelos renais agudos

A insuficiência renal aguda (IRA) é uma patologia que apresenta alta incidência na população e elevada morbimortalidade. Apesar de todos os avanços terapêuticos já obtidos, essas taxas ainda continuam elevadas. Uma possível alternativa, atualmente sugerida, seria o transplante de células-tronco. O processo regenerativo das células-tronco mesenquimais (CTMs) já foi demonstrado em diversos modelos experimentais e em alguns ensaios clínicos. O mecanismo de ação mais sugerido é a ação parácrina das CTMs na área lesada. Ainda, sabe-se que nesse ambiente, citocinas pró-inflamatórias, como TNF-α e IFNγ, ativam as CTMs para seu papel reparador. O presente estudo busca analisar o papel do IFNγ na ativação das CTMs em modelos renais. As CTMs de animais nocautes para receptor de IFNγ (IFNγR KO) e de animais selvagens (controle/ C57/Bl6) foram isoladas do tecido adiposo. Essas células foram caracterizadas por imunofenotipagem e diferenciação em adipócitos e osteócitos. A lesão renal aguda foi obtida através do clampeamento dos pedículos renais de camundongos machos C57/Bl6, por 45 min. Após 4hs da lesão isquêmica, as CTMs IFNγR KO e CTMs controles foram administradas intraperitonealmente, e 24hs após a cirurgia os animais foram sacrificados. O tratamento com CTMs selvagens apresentou significativa redução dos níveis de uréia e creatinina sérica. No entanto, a redução desses níveis séricos com CTMs IFNγR KO foi menos intensa. Com relação à análise da resposta inflamatória do rim, os dados demonstram que a expressão de RNAm de IL-6 é maior nos animais tratados com CTMs IFNγR KO quando comparada ao tratamento com CTMs selvagens; porém, os dois tratamentos apresentam expressão reduzida em comparação aos animais não tratados. Já a expressão de RNAm de IL-10 é maior em animais tratados com CTMs em comparação aos não tratados... (Resumo completo, clicar acesso eletrônico abaixo)

Marcadores de superfície de Células-tronco: estudo de reação cruzada inter-espécies

Mesenchymal stem cells (MSCs) are adult multipotent cells with fibroblastoid morphology and adherent to plastic. Furthermore, they can be obtained from different sources. Besides bone marrow, these cells are taken from umbilical cord blood, umbilical vein, saphenous vein, peripheral blood, arteries, liver and fetal pancreas, placenta, dental pulp and adipose tissue. MSCs derived from adipose tissue are important because of the abundant number of cells that can be obtained from this tissue, easy access and little discomfort to the patient. This study compared two techniques for obtaining MSCs from adipose tissue: mechanical dissociation (MD) and enzymatic digestion (ED). We also analyzed the inter-species cross-reactions using commercial monoclonal antibodies directed against surface antigens of stem cells from different species: mouse, horse, rabbit, monkey and human. We found that MD technique is favorable in relation to ED within 15 days of culture, and ED is more efficient in the first days of culture. The data also showed that MD causes less damage to cellular DNA. About inter-species cross-reactions, the monoclonal antibody A69 directed against stem cells from rabbits, which can be used in veterinary medicine, particularly in research involving horses

Diferenciação miogênica “in vitro” de células tronco mesenquimais murinas de diferentes origens

Muscular dystrophy refers to a group of more than 30 genetical disorders characterized by progressive weakness and degeneration of the skeletal muscle. No effective therapy is available at present. Recent studies have reported that the transplantation of stem cells can offer an important potential therapy for genetic diseases. Adult bone marrow mesenchymal stem cells have been identified as a nonhematopoietic stem cell population capable of self-renewal with the ability to differentiate into many cell lineages, including bone, fat, cartilage and connective tissue. Because of their similarity with muscle progenitor cells, when they are injected in affected individuals, they are able to migrate into areas of skeletal muscle degeneration and participate in the regeneration process. The adipose tissue represents an alternative source of MSCs that, as the MSCs derived from bone marrow, are capable of in vitro differentiation into osteogenic, adipogenic, myogenic and chondrogenic lineages. The objective of this project is to investigate the “in vitro” myogenic potential of mesenchymal stem cells derived from murine bone marrow and adipose tissue. Four experimental groups were analyzed: mice from lineages Lama2dy-2J/J and C57black and, C2C12 lineage cells and transformed C2C12 expressing the eGFP protein. MSCs cultures were obtained by flushing the bone marrow femurs and tibials with α-MEM or by the subcutaneous and inguinal fat from the mice. Their characterization was done by flow cytometry and in vitro differentiation. Muscle differentiation was studied through the analysis of the expression of transcriptional factors involved in muscle differentiation and/or the presence and amount of specific proteins from muscle differentiated cell. The pluripotency from bone marrow MSCs of the two lineages was evidenced and, in the muscular differentiation... (Complete abstract click electronic access below)

Influência de diferentes extratos de Cordia ecalyculata em cultura de células-tronco mesenquimais humanas

Diante da constatação clínica de que muitos pacientes não conseguem benefício completo da remissão da ulceração em membros inferiores com os tratamentos convencionais, o Setor de Biotecnologia do Hemocentro de Botucatu estabeleceu o protocolo de produção de curativos bioativos, que interagem com a lesão e estimulam via hormônios de crescimento (PDGF, VEFG, FGF e outros) a recuperação da área danificada por indução das células-tronco comissionadas da pele. Estudos realizados na Faculdade de Química de Araraquara culminaram com a purificação do princípio ativo do fitoterápico Cordia ecalyculata para analisar in vitro o seu alto potencial antiinflamatório. Seus diferentes extratos foram enviados ao Laboratório de Engenharia Celular da Faculdade de Medicina de Botucatu: extrato bruto (EB), fase aquosa (FA), fase hexânica (FH) e fase etérea (FE), que foram testados em diferentes concentrações em cultura de células-tronco mesenquimais humanas (CTM), oriundas de tecido adiposo, com a finalidade de analisar, através de caspase-3, marcador intracelular, o índice de apoptose. Aquele que apresentar o melhor resultado será adicionado à fórmula dos biocurativos. Este trabalho tem os objetivos de avaliar a contribuição da cultura celular de CTM nos testes de tolerância com Cordia ecalyculata, estabelecer o índice de apoptose celular e avaliar o tempo de confluência maior que 80% na cultura de CTM em diferentes concentrações de C. ecalyculata. Os resultados encontrados comprovaram que os extratos que apresentaram os melhores desempenhos foram os da FA em todas as concentrações e FE de 25μg/mL. Os extratos FE nas demais concentrações demonstraram um desempenho insatisfatório,o que nos indica que uma concentração entre 25 e 50μg/mL seja o limite entre a boa execução nas células e toxicidade. Mais testes terão que ser realizados para demonstrar qual é essa concentração de FA é realmente melhor a ser utilizada